Imeglimin hydrochloride
Imeglimin is an oral glucose-lowering agent that targets mitochondrial bioenergetics, improving insulin secretion and glucose uptake while reducing reactive oxygen species.
- The description claims that imeglimin decreases reactive oxygen species overproduction and delays mPTP opening, preventing cell death during oxidative stress, protecting beta-cells.
AI Readiness
Good foundation, but some important product data is still missing.
66%